Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01621711 · ClinicalTrials.gov registry record · NA

Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care

A NA study of Substance Abuse and Alcohol Abuse, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
504
Enrollment target
1
Study location

NCT01621711 is a NA study of Substance Abuse and Alcohol Abuse that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 504 participants, below the 5,251-participant average among 58 other Substance Abuse trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01621711, a NA study of Substance Abuse and Alcohol Abuse, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
504 participants
Enrollment target
1
Study location

Study Summary

This component of a larger Center of Research Excellence Grant improves treatment for drug abuse by developing effective linkages between specialty drug treatment and primary health care.

Interventions

  • BEHAVIORAL Linkage patient activation intervention

Study Locations (1)

California

  • Kaiser Permanente, Chemical Dependency Recovery Program - San Francisco

Trial Details

FieldValue
Enrollment Target 504 participants
Start Date 2011-03
Est. Completion 2025-12-31
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT01621711

The ClinicalTrials.gov registry entry for NCT01621711 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 504 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,251-participant average among 58 other Substance Abuse trials with a reported enrollment target (90% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which Linkage patient activation intervention is the first listed.

NCT01621711 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01621711 about?

NCT01621711 is a clinical study titled "Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care". This component of a larger Center of Research Excellence Grant improves treatment for drug abuse by developing effective linkages between specialty drug treatment and primary health care.

What is the current status of trial NCT01621711?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 504 participants. The study started on 2011-03. Estimated completion is 2025-12-31.

What conditions does trial NCT01621711 study?

This clinical trial studies the following conditions: Substance Abuse, Alcohol Abuse, Substance Dependence, Substance Addiction.

What interventions are being tested in trial NCT01621711?

The interventions under investigation include: Linkage patient activation intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01621711?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01621711 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.